BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 24331115)

  • 1. Does dehydroepiandrosterone supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve?
    Kara M; Aydin T; Aran T; Turktekin N; Ozdemir B
    Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():63-5. PubMed ID: 24331115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study on role of dehydroepiandrosterone (DHEA) on improving the ovarian reserve markers in infertile patients with poor ovarian reserve.
    Singh N; Zangmo R; Kumar S; Roy KK; Sharma JB; Malhotra N; Vanamail P
    Gynecol Endocrinol; 2013 Nov; 29(11):989-92. PubMed ID: 24004296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders.
    Yeung TW; Chai J; Li RH; Lee VC; Ho PC; Ng EH
    Fertil Steril; 2014 Jul; 102(1):108-115.e1. PubMed ID: 24796766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
    Lefebvre J; Antaki R; Kadoch IJ; Dean NL; Sylvestre C; Bissonnette F; Benoit J; Ménard S; Lapensée L
    Fertil Steril; 2015 Dec; 104(6):1419-25. PubMed ID: 26361207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does dehydroepiandrosterone improve pregnancy rate in women undergoing IVF/ICSI with expected poor ovarian response according to the Bologna criteria? A randomized controlled trial.
    Kotb MM; Hassan AM; AwadAllah AM
    Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():11-5. PubMed ID: 26963897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of dehydroepiandrosterone supplementation on ovarian response is associated with androgen receptor in diminished ovarian reserve women.
    Hu Q; Hong L; Nie M; Wang Q; Fang Y; Dai Y; Zhai Y; Wang S; Yin C; Yang X
    J Ovarian Res; 2017 May; 10(1):32. PubMed ID: 28472976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the modified natural in vitro fertilization cycle justified in patients with "genuine" poor response to controlled ovarian hyperstimulation?
    Kedem A; Tsur A; Haas J; Yerushalmi GM; Hourvitz A; Machtinger R; Orvieto R
    Fertil Steril; 2014 Jun; 101(6):1624-8. PubMed ID: 24680364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Dehydroepiandrosterone (DHEA) to overcome the effect of ovarian ageing (DITTO): A proof of principle double blinded randomized placebo controlled trial.
    Narkwichean A; Maalouf W; Baumgarten M; Polanski L; Raine-Fenning N; Campbell B; Jayaprakasan K
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():39-48. PubMed ID: 28934714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dehydroepiandrosterone plus climen supplementation shows better effects than dehydroepiandrosterone alone on infertility patients with diminished ovarian reserve of low-FSH level undergoing in-vitro fertilization cycles: a randomized controlled trial.
    Zhang H; Chu Y; Zhou P; He X; Xu Q; Zhang Z; Cao Y; Wei Z
    Reprod Biol Endocrinol; 2016 Feb; 14():9. PubMed ID: 26879683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: serum AMH, inhibin B and antral follicle count.
    Yilmaz N; Uygur D; Inal H; Gorkem U; Cicek N; Mollamahmutoglu L
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):257-60. PubMed ID: 23664458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dehydroepiandrosterone supplementation in women undergoing assisted reproductive technology with poor ovarian response. A prospective case-control study.
    Al-Turki HA
    J Int Med Res; 2018 Jan; 46(1):143-149. PubMed ID: 28758852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biopsying, fragmentation and autotransplantation of fresh ovarian cortical tissue in infertile women with diminished ovarian reserve.
    Lunding SA; Pors SE; Kristensen SG; Landersoe SK; Jeppesen JV; Flachs EM; Pinborg A; Macklon KT; Pedersen AT; Andersen CY; Andersen AN
    Hum Reprod; 2019 Oct; 34(10):1924-1936. PubMed ID: 31593582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dehydroepiandrosterone supplementation on women with poor ovarian response: A preliminary report and review.
    Tsui KH; Lin LT; Chang R; Huang BS; Cheng JT; Wang PH
    Taiwan J Obstet Gynecol; 2015 Apr; 54(2):131-6. PubMed ID: 25951716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of cystectomy for ovary benign cyst on ovarian reserve and pregnancy outcome of in vitro fertilization-embryo transfer cycle].
    Zhang XR; Ding LL; Tang R; Sheng Y; Qin YY; Chen ZJ
    Zhonghua Fu Chan Ke Za Zhi; 2016 Mar; 51(3):180-5. PubMed ID: 27030496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR).
    Gleicher N; Kim A; Weghofer A; Shohat-Tal A; Lazzaroni E; Lee HJ; Barad DH
    J Assist Reprod Genet; 2013 Jan; 30(1):49-62. PubMed ID: 23212832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind randomised controlled trial on the effect of dehydroepiandrosterone on ovarian reserve markers, ovarian response and number of oocytes in anticipated normal ovarian responders.
    Yeung T; Chai J; Li R; Lee V; Ho PC; Ng E
    BJOG; 2016 Jun; 123(7):1097-105. PubMed ID: 26663817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A meta-analysis of dehydroepiandrosterone supplementation among women with diminished ovarian reserve undergoing in vitro fertilization or intracytoplasmic sperm injection.
    Li J; Yuan H; Chen Y; Wu H; Wu H; Li L
    Int J Gynaecol Obstet; 2015 Dec; 131(3):240-5. PubMed ID: 26421833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between anti-Müllerian hormone and IVF-ICSI outcome in poor responder patients performing long protocol.
    Aydin T; Kara M; Aran T; Turktekin N; Ozdemir B
    Clin Exp Obstet Gynecol; 2015; 42(5):663-5. PubMed ID: 26524819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of dehydroepiandrosterone priming in women with poor ovarian response undergoing IVF/ICSI: a meta-analysis.
    Zhang J; Jia H; Diao F; Ma X; Liu J; Cui Y
    Front Endocrinol (Lausanne); 2023; 14():1156280. PubMed ID: 37361534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.